학술논문
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
Document Type
Article
Author
Source
In: Clinical Ophthalmology . (Clinical Ophthalmology, 2023, 17:3601-3611)
Subject
Language
English
ISSN
11775483
11775467
11775467